• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. LGN OX CONSTRAINED FEM 4 RT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. LGN OX CONSTRAINED FEM 4 RT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Model Number 71421174
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code Limb Fracture (4518)
Date of Event 07/27/2021
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after total knee replacement surgery had been performed on (b)(6) 2016, the implanted legion oxinium constrained femoral size 4 - right broke in half.This adverse event was treated by revision surgery completed on (b)(6) 2021.Current health status of patient is unknown.
 
Additional Manufacturer Narrative
The device, used in treatment, was not returned for evaluation but the images provided were reviewed, and the fracture was confirmed.The clinical/medical investigation concluded that, based on the limited information provided the clinical root cause of the reported breakage could not be determined, however, we are unable to rule out the patient¿s body habitus of 301lbs as a contributing factor to the implant breakage.The future impact to the patient beyond the revision cannot be determined.Should additional information become available this issue can be re-elevated.No further clinical assessment is warranted at this time.A review of the complaint history for the listed part revealed no prior complaints for the listed failure.A review of the risk management file and instructions for use documents revealed this failure mode was previously identified.At this time, we have no reason to suspect that the product failed to meet any product specifications at the time of manufacture.Some potential probable causes for this event could include but are not limited to abnormal loading of limb or excessive forces applied to implant or patient condition.Based on this investigation, the need for corrective action is not indicated.Without the return of the actual product involved, our investigation could not proceed.Should the device or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LGN OX CONSTRAINED FEM 4 RT
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
MDR Report Key12304831
Report Number1020279-2021-06286
Device Sequence Number3971125
Product Code JWH
UDI-Device Identifier03596010543905
UDI-Public03596010543905
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K043440
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2021
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 09/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number71421174
Device Catalogue Number71421174
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/27/2021
Supplement Date Received by Manufacturer09/09/2021
Initial Report FDA Received Date08/10/2021
Supplement Report FDA Received Date09/10/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Weight137
-
-